Who Exports Semaglutide from India — 140 Suppliers Behind a $5.0M Market
India's semaglutide export market is supplied by 140 active exporters who collectively shipped $5.0M across 2,503 shipments. KARDI TRADING PRIVATE LIMITED leads with a 24.3% market share, followed by PLEASANT EXPORTS and LOTUS INTERNATIONAL. The top 5 suppliers together control 59.8% of total export value, reflecting a moderately competitive market structure.
Top Semaglutide Exporters from India — Ranked by Export Value
KARDI TRADING PRIVATE LIMITED is the leading semaglutide exporter from India, holding a 24.3% share of the $5.0M market across 2,503 shipments from 140 exporters. The top 5 suppliers — KARDI TRADING PRIVATE LIMITED, PLEASANT EXPORTS, LOTUS INTERNATIONAL, GAIA TRADE PRIVATE LIMITED, PRECISE BIOPHARMA PRIVATE LIMITED — collectively control 59.8% of total export value, indicating a moderately concentrated market. Individual shares are: KARDI TRADING PRIVATE LIMITED (24.3%), PLEASANT EXPORTS (16.4%), LOTUS INTERNATIONAL (7.3%), GAIA TRADE PRIVATE LIMITED (7.0%), PRECISE BIOPHARMA PRIVATE LIMITED (4.8%).
Top Semaglutide Exporters from India
Ranked by export value · 140 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | KARDI TRADING PRIVATE LIMITED SEMAGLUTIDE 7MG TABS NOSSEMAGLUTIDE 14 MGSEMAGLUTIDE 7MG TABLETS NOS | $1.2M | 4 | 24.3% |
| 2 | PLEASANT EXPORTS RYBELSUS 3 MG 10 TAB SEMAGLUTIDERYBELSUS 14 TABRYBELSUS 14 TAB NOS | $814.8K | 3 | 16.4% |
| 3 | LOTUS INTERNATIONAL SEMAGLUTIDE 14 MGSEMAGLUTIDE 7MG TABS NOS | $361.5K | 3 | 7.3% |
| 4 | GAIA TRADE PRIVATE LIMITED RYBELSUS 7MG NOVO NORDISK SEMAGLUTIDERYBELSUSRYBELSUS 14MGRYBELSUS 7MG NOVO NORDISK, SEMAGLUTIDERYBELSUS | $350.1K | 3 | 7.0% |
| 5 | PRECISE BIOPHARMA PRIVATE LIMITED SEMAGLUTIDE INJECTION PF PEN 4MG 3MLSEMAGLUTIDE INJECTION PF PEN 4MG 3ML 3687 PENSSEMAGLUTIDE INJECTION PF PEN 2MG 3ML | $238.9K | 1 | 4.8% |
| 6 | GMSANJIVANI LLP SEMAGLUTIDE 14 MGSEMAGLUTIDE 7MG TABS NOSRYBELSUS 3MG | $228.1K | 2 | 4.6% |
| 7 | HEXA HEALTHCARE PVT LTD RYBELSUS 3 MG 10 TAB SEMAGLUTIDERYBELSUS 14 TABRYBELSUS 14 TAB NOS | $214.3K | 1 | 4.3% |
| 8 | GANPATI EXIM INC SEMAGLUTIDE 14 MGSEMAGLUTIDE 7MG TABS NOS | $148.9K | 1 | 3.0% |
| 9 | SAVA HEALTHCARE LIMITED RYBELSUS 3 MG 10 TAB SEMAGLUTIDERYBELSUS 14 TABRYBELSUS 14 TAB NOS | $117.4K | 1 | 2.4% |
| 10 | VINAYAK PHARMA CORP RYBELSUS 3MG | $114.4K | 1 | 2.3% |
| 11 | CELUTE LIFESCIENCES PRIVATE LIMITED SEMAGLUTIDE 7MG TABS NOSSEMAGLUTIDE 14MG TABS | $93.5K | 1 | 1.9% |
| 12 | ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED RYBELSUS 7MG NOVO NORDISK SEMAGLUTIDERYBELSUSRYBELSUS 14MGRYBELSUS 7MG NOVO NORDISK, SEMAGLUTIDERYBELSUS | $89.5K | 3 | 1.8% |
| 13 | LAWRENCE WALTER | $65.0K | 2 | 1.3% |
| 14 | SAVIOUR INTERNATIONAL SEMAGLUTIDE 14 MGSEMAGLUTIDE 7MG TABS NOS | $53.3K | 1 | 1.1% |
| 15 | HEXA HEALTH CARE PRIVATE LIMITED RYBELSUS 3 MG 10 TAB SEMAGLUTIDERYBELSUS 14 TABRYBELSUS 14 TAB NOS | $42.2K | 1 | 0.8% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Semaglutide exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| ACULIFE HEALTHCARE PRIVATE LIMITED | Not Listed | Yes, as of September | No | Not verified | WHO-GMP certified for large and small volume parenterals, inhalers, and ophthalm |
| CENTURION LABORATORIES PVT. LTD. | Not Listed | Yes, as of March 11, | No | Not verified | WHO-GMP certified; inspected by the Philippine FDA with certificate valid until |
| MEDIBIOS LABORATORIES PVT. LTD. | Not Listed | Yes, as of March 16, | No | Not verified | WHO-GMP certified; inspected by the Philippine FDA with certificate valid until |
| COOPER PHARMA LIMITED | Not Listed | Yes, as of March 16, | No | Not verified | WHO-GMP certified; inspected by the Philippine FDA with certificate valid until |
TransData Nexus reviewed the regulatory standing of 4 leading Semaglutide exporters from India. 0 hold US FDA facility approvals, 4 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Semaglutide sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal center for active pharmaceutical ingredient (API) production. The city hosts over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy’s Laboratories, Aurobindo Pharma, and Divi’s Laboratories. The presence of Genome Valley, India's first biotech cluster, along with esteemed institutions like the National Institute of Pharmaceutical Education and Research (NIPER) and the Indian Institute of Chemical Technology (IICT), fosters a robust environment for pharmaceutical research and development.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its expertise in pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with major companies such as Zydus Cadila, Intas Pharmaceuticals, Torrent Pharmaceuticals, and Cadila Pharmaceuticals headquartered in the region. The state's well-developed infrastructure, including ports, roads, and utilities, supports efficient manufacturing and distribution processes.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being the financial capital, provides access to international markets and regulatory bodies. The region is home to numerous pharmaceutical companies that leverage the strategic location and established logistics networks to facilitate global distribution.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, has emerged as Asia's largest pharmaceutical hub, housing over 1,000 manufacturing units. The region's growth is attributed to favorable government policies, including tax incentives and a Special Economic Zone (SEZ) status, which have attracted both domestic and international pharmaceutical companies. Baddi's strategic location near Chandigarh and its robust infrastructure make it a preferred destination for pharmaceutical manufacturing.
5Sourcing Recommendations
- Evaluate Supplier Capabilities: Assess the technical expertise and production capacities of suppliers in Hyderabad for API procurement, ensuring they meet quality standards and regulatory requirements.
- Leverage Formulation Expertise: Engage with manufacturers in the Ahmedabad-Vadodara region for formulation development, taking advantage of their established infrastructure and experience in producing finished dosage forms.
- Optimize Export Logistics: Utilize the Mumbai-Thane-Raigad corridor for efficient export operations, benefiting from the region's proximity to international shipping routes and regulatory agencies.
- Consider Cost Advantages: Explore manufacturing opportunities in Baddi-Nalagarh to capitalize on tax incentives and cost-effective production capabilities, while ensuring compliance with quality standards.
By strategically engaging with these pharmaceutical clusters, companies can enhance their supply chain efficiency and competitiveness in the semaglutide market.
Common Questions — Semaglutide Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which semaglutide supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, KARDI TRADING PRIVATE LIMITED leads with 41 recorded shipments worth $1.2M. PLEASANT EXPORTS (98 shipments) and LOTUS INTERNATIONAL (28 shipments) are also established high-volume exporters.
Q How many semaglutide manufacturers are there in India?
India has 140 active semaglutide exporters with a combined export market of $5.0M across 2,503 shipments to 69 countries. The top 5 suppliers hold 59.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for semaglutide from India?
Average FOB unit price: $108.33 per unit, ranging from $0.00 to $22530.69. Average shipment value: $2.0K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 140 verified Indian exporters of Semaglutide ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 2,503 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 69 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,503 Verified Shipments
140 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists